Comparative Safety of Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Patients Undergoing Treatment for Rheumatoid Arthritis

Yao-Fan Fang; Lai-Chu See

Comparative Safety of Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Patients Undergoing Treatment for Rheumatoid Arthritis

Department of Public Health

Research output: Contribution to journal › Journal Article › peer-review

Original language	American English
Pages (from-to)	2744-2747
Journal	Arthritis & rheumatology (Hoboken, N.J.)
Volume	74
State	Published - 2022

Cite this

@article{281acacbada14144953767c2a0a7c7cb,

title = "Comparative Safety of Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Patients Undergoing Treatment for Rheumatoid Arthritis",

author = "Yao-Fan Fang and Lai-Chu See",

year = "2022",

language = "American English",

volume = "74",

pages = "2744--2747",

journal = "Arthritis & rheumatology (Hoboken, N.J.)",

issn = "2326-5191",

publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Comparative Safety of Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Patients Undergoing Treatment for Rheumatoid Arthritis

AU - Fang, Yao-Fan

AU - See, Lai-Chu

PY - 2022

Y1 - 2022

M3 - Journal Article

SN - 2326-5191

VL - 74

SP - 2744

EP - 2747

JO - Arthritis & rheumatology (Hoboken, N.J.)

JF - Arthritis & rheumatology (Hoboken, N.J.)

ER -